Is there a role of MMA T wave alternans test for risk assessment in Brugada syndrome? (Author`s Reply)

References (3)

1. Yalın K, Gölcük E, Teker E, Bilge AK, Adalet K. Is there a role of MMA T wave alternans test for risk assessment in Brugada syndrome? Anadolu Kardiyol Derg 2013; 13: 702-4
2. Mizumaki K, Fujiki A, Tsuneda T, Sakabe M, Nishida K, Sugao M, et al. Vagal activity modulates spontaneous augmentation of ST elevation in the daily life of patients with Brugada syndrome. J Cardiovasc Electrophysiol 2004; 6: 667-73. [CrossRef] 3. Conte G, Sieira J, Sarkozy A, Asmundis C, Di Giovanny G, Chierchia GB, et al. Life-threatening ventricular arrhythmias during ajmaline challenge in patients with Brugada syndrome: Incidence, clinical features, and prognosis. Heart Rhythm 2013; 13: 1070-9
3. Verrier RL, Ikeda T. Ambulatory ECG-based T-wave alternans monitoring for risk assessment and guiding medical therapy: mechanisms and clinical applications. Prog Cardiovasc Dis 2013; 56: 172-85. [CrossRef] 5. Yoshioka K, Amino M, Zareba W, Shima M, Matsuzaki A, Fujii T, et al. Identification of high-risk Brugada syndrome patients by combined analysis of late potential and T-wave amplitude variability on ambulatory electrocardiograms. Circ J 2013; 77: 610-8. [CrossRef] 6. Abe A, Kobayashi K, Yuzawa H, Sato H, Fukunaga S, Fujino T, et al. Comparison of late potentials for 24 hours between Brugada syndrome and arrhythmogenic right ventricular cardiomyopathy using a novel signal-averaging system based on Holter ECG. Circ Arrhythm Electrophysiol 2012; 5: 789-95. [CrossRef]